Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Cash: 2012-2025

Historic Change in Cash for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $96.7 million.

  • Veracyte's Change in Cash rose 154.42% to $96.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 40.80%. This contributed to the annual value of $23.7 million for FY2024, which is 61.94% down from last year.
  • Veracyte's Change in Cash amounted to $96.7 million in Q3 2025, which was up 194.69% from $32.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Change in Cash ranged from a high of $96.7 million in Q3 2025 and a low of -$163.5 million during Q3 2021.
  • Its 3-year average for Change in Cash is $14.8 million, with a median of $13.9 million in 2023.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 346.74% in 2023, then tumbled by 649.86% in 2025.
  • Over the past 5 years, Veracyte's Change in Cash (Quarterly) stood at $9.2 million in 2021, then plummeted by 273.05% to -$15.9 million in 2022, then surged by 187.38% to $13.9 million in 2023, then crashed by 346.17% to -$34.1 million in 2024, then soared by 154.42% to $96.7 million in 2025.
  • Its Change in Cash was $96.7 million in Q3 2025, compared to $32.8 million in Q2 2025 and -$52.9 million in Q1 2025.